ChangeNOW CSO Pauline Shangett digs into the infrastructure underpinning the exchange’s simple, streamlined frontend.

Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal fourth ...

A former Arby’s manager in Oklahoma has been arrested after she allegedly infected a customer and her family with oral herpes ...

A former Arby's manager in Oklahoma is facing criminal charges and a civil lawsuit after allegedly spitting into a customer's ...

Scavenge for gold, coins, and other buried treasure with these metal detectors, including models from Nokta and Minelab.

Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...

An Oklahoma woman sues Arby's after allegedly contracting herpes from a contaminated sandwich. The lawsuit follows a ...

Arby's Customer Sues Store Manager After Allegedly Contaminated Sandwich Left Her With a Lifelong Viral Infection ...

One of the most recurring issues in construction contracts, typically in public-works contracts, is the validity of ‘no-claim ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food and Drug Administration ...

Down 32% from all-time highs, TerraVest is a TSX dividend stock that offers you significant upside potential in June 2026.

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...